DaltonTx Launches Advanced Antibody Discovery Capabilities for AI-Driven Drug Development

New capabilities enable researchers to analyse, characterise and prioritise antibody candidates at scale  Integrated AI models and workflows suppor...

October 02, 2026 | Friday | News
SkinHealth Systems Expands SkinStylus Microneedling Device Across Six European Markets

SkinHealth Systems (Nasdaq: SKIN), home to flagship brand Hydrafacial™, announced the European expansion of the SkinStylus® SteriLock® MicroS...

October 02, 2026 | Friday | News
Vanda Reports Positive Phase III Results for HETLIOZ in Delayed Sleep-Wake Phase Disorder

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced positive topline results from its pivotal Phase III study of HETLIOZ® (tasimelteon) 20 mg in a...

October 01, 2026 | Thursday | News
Terumo Neuro to Acquire Arsenal Medical to Expand Liquid Embolic Portfolio

Terumo Neuro announced that it has signed an agreement to acquire Arsenal Medical Inc., a privately held, clinical-stage biomaterials company developing Ne...

October 01, 2026 | Thursday | News
Verdiva Bio Presents VRB-103 Oral Amylin Data for Obesity Treatment

Verdiva Bio Limited (“Verdiva Bio” or “the Company”), a clinical-stage biotechnology company advancing the development of a portfol...

September 30, 2026 | Wednesday | News
Innovent Reports Phase 1 Data for IBI3003 Trispecific Antibody in Multiple Myeloma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercializat...

September 30, 2026 | Wednesday | News
Kither Biotech Doses First Patients in KIT2014 COPD Clinical Trial

KIT2014 is a novel inhaled peptide therapy being developed for respiratory diseases including chronic obstructive pulmonary disease (COPD), non-CF bronch...

September 30, 2026 | Wednesday | News
Novartis Receives Positive CHMP Opinion for Cosentyx in Polymyalgia Rheumatica

Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion r...

September 21, 2026 | Monday | News
Teva Reports Real-World Data Showing UZEDY Supports Treatment Continuity and Reduces Healthcare Utilization in Schizophrenia

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.  announced new real-world data evaluating treatment continuity, health...

September 21, 2026 | Monday | News
Aptar Pharma and Massachusetts General Hospital Partner to Advance Nose-to-Brain Drug Delivery

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, announced that it has...

September 16, 2026 | Wednesday | News
NRx Pharmaceuticals Deploys FDA-Cleared Robotic TMS System at HOPE Clinics

HOPE is the first Interventional Psychiatry network to deploy Zeta Surgical's newly FDA-cleared TMS Robotic System; the HOPE clinical team is completin...

September 14, 2026 | Monday | News
Omniscient Gains FDA 510(k) Clearance for Quicktome Deep Brain DBS Workflow

Omniscient announced 510(k) clearance from the U.S. Food and Drug Administration for a new workflow within the Quicktome® platform: Quicktome Deep Br...

September 14, 2026 | Monday | News
Insilico Medicine Doses First Patient in Phase III Trial of AI-Discovered Rentosertib for IPF

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, announced that it has dosed the first patien...

September 11, 2026 | Friday | News
Nanox Expands U.S. Distribution Network Through New England Partnership

Expands Nanox’s growing U.S. distribution network with a leading New England-based medical imaging provider Nano-X Imaging Ltd. (“Nanox&rdqu...

September 08, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close